Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Other Non-Current Assets came in at $294.0 million in Q2 2026, down 3.61% on a YoY basis from $305.0 million in Q2 2025, and down 2.65% quarter-over-quarter from $302.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Other Non-Current Assets for 6 consecutive years, with $294.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets fell 3.61% year-over-year to $294.0 million; the trailing twelve-month figure through Jun 2026 stood at $294.0 million (down 3.61% YoY), and the FY2025 full-year result was $310.0 million, up 5.44% from the prior year.
- Other Non-Current Assets declined to $294.0 million in Q2 2026 per BLCO's latest filing, from $302.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $310.0 million in Q3 2024 and bottomed at $188.0 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $255.7 million across 5 years, with a median of $240.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets declined 7.02% in 2023, then jumped 46.23% in 2024.
- Over 5 years, Other Non-Current Assets stood at $215.0 million in 2022, then rose by 4.65% to $225.0 million in 2023, then jumped by 30.67% to $294.0 million in 2024, then advanced by 5.44% to $310.0 million in 2025, then dropped by 5.16% to $294.0 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $294.0 million, $302.0 million, and $310.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 294.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 294.00 Mn |
| Mar 31, 2026 | 302.00 Mn |
| Dec 31, 2025 | 310.00 Mn |
| Sep 30, 2025 | 303.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 295.00 Mn |
| Dec 31, 2024 | 294.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 249.00 Mn |
| Mar 31, 2024 | 231.00 Mn |
| Dec 31, 2023 | 225.00 Mn |
| Sep 30, 2023 | 212.00 Mn |
| Jun 30, 2023 | 207.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 228.00 Mn |
| Jun 30, 2022 | 222.00 Mn |
| Mar 31, 2022 | 188.00 Mn |
| Dec 31, 2021 | 180.00 Mn |